Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Hepatitis C"" wg kryterium: Temat


Starter badań:

Tytuł:
Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.
Autorzy:
Busschots D; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, Diepenbeek, 3500, Hasselt, Belgium. .; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium. .
Kremer C; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-Biostat), Data Science Institute, Hasselt University, Diepenbeek, Belgium.
Bielen R; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, Diepenbeek, 3500, Hasselt, Belgium.; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Koc ÖM; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, Diepenbeek, 3500, Hasselt, Belgium.; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.; Medical Microbiology, School of NUTRIM, Maastricht University Medical Centre, Maastricht, the Netherlands.
Heyens L; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, Diepenbeek, 3500, Hasselt, Belgium.; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.; School of NUTRIM, Maastricht University Medical Centre, Maastricht, the Netherlands.
Nevens F; Department of Gastroenterology and Hepatology, University Hospitals KU, Leuven, Belgium.
Hens N; Interuniversity Institute for Biostatistics and Statistical Bioinformatics (I-Biostat), Data Science Institute, Hasselt University, Diepenbeek, Belgium.; Centre for Health Economic Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Robaeys G; Faculty of Medicine and Life Sciences, Hasselt University, Martelarenlaan 42, Diepenbeek, 3500, Hasselt, Belgium.; Department of Gastroenterology and Hepatology, Ziekenhuis Oost-Limburg, Genk, Belgium.; Department of Gastroenterology and Hepatology, University Hospitals KU, Leuven, Belgium.
Pokaż więcej
Źródło:
BMC public health [BMC Public Health] 2022 Nov 24; Vol. 22 (1), pp. 2159. Date of Electronic Publication: 2022 Nov 24.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C, Chronic*
Hepatitis C*/epidemiology
Prisoners*
Humans ; Hepacivirus ; Prevalence ; Antiviral Agents ; Hepatitis C Antibodies
Czasopismo naukowe
Tytuł:
An adaptable platform for in-house hepatitis C serology.
Autorzy:
Pedersen J; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Canada.
Moukandja IP; Centre Hospitalier Universitaire de Libreville, Libreville BP2228, Gabon.
Ndidi S; Centre Hospitalier Universitaire de Libreville, Libreville BP2228, Gabon.
Sørensen AL; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Koumakpayi IH; Centre Hospitalier Universitaire de Libreville, Libreville BP2228, Gabon.
Lekana-Douki JB; Unité d'Evolution Epidémiologie et Résistances Parasitaires, Centre Interdisciplinaire de Recherches Médicales de Franceville, Franceville, Gabon.
Vachon ML; Axe des Maladies Infectieuses et Immunitaires, Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval, Québec G1V 4G2, Canada.
Weis N; Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Kobinger G; Galveston National Laboratory, Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, USA.
Fausther-Bovendo H; Département de Microbiologie-Infectiologie et Immunologie, Faculté de Médecine, Université Laval, Québec, Canada; Global Urgent and Advanced Research and Development - GUARD, 911 Rue Principale, unit 100, Batiscan, Quebec G0X 1A0, Canada. Electronic address: .
Pokaż więcej
Źródło:
Journal of virological methods [J Virol Methods] 2022 Oct; Vol. 308, pp. 114586. Date of Electronic Publication: 2022 Jul 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepacivirus*
Hepatitis C*/diagnosis
Enzyme-Linked Immunosorbent Assay/methods ; Hepatitis C Antibodies ; Hepatitis C Antigens ; Humans ; Neglected Diseases ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Meta-analysis: diagnostic accuracy of hepatitis C core antigen detection during therapy with direct-acting antivirals.
Autorzy:
Sepúlveda-Crespo D; Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
Treviño-Nakoura A; Servicio de Medicina Preventiva y Salud Pública, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
Bellon JM; Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain.
Ardizone Jiménez B; Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.
Jiménez-Sousa MA; Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Fernández-Rodríguez A; Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Martínez I; Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Resino S; Unidad de Infección Viral e Inmunidad, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
Pokaż więcej
Źródło:
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2022 Oct; Vol. 56 (8), pp. 1224-1234. Date of Electronic Publication: 2022 Aug 28.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C, Chronic*/diagnosis
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Hepatitis C Antigens/genetics ; Hepatitis C Antigens/therapeutic use ; Humans ; RNA, Viral
Czasopismo naukowe
Tytuł:
Factors associated with hepatitis B and C among adults in Buea, Cameroon: A community-based cross-sectional study.
Autorzy:
Tazinkeng NN; Faculty of Health Sciences, University of Buea, Buea, Cameroon.; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; Department of Population Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.
Teuwafeu DG; Faculty of Health Sciences, University of Buea, Buea, Cameroon.; Department of Internal Medicine, Buea Regional Hospital, Buea, Cameroon.
Asombang AW; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Agbor VN; Department of Population Health Research, Health Education and Research Organization (HERO), Buea, Cameroon.; Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
Bloom SM; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, Massachusetts, USA.
Nkhoma AN; Pan-African Organization for Health, Education and Research, Manchester, Missouri, USA.; University Hospital of the North Midlands NHS Trust, Stoke-on-Trent, UK.
Mohareb AM; Harvard Medical School, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.
Luma HN; Douala General Hospital, Douala, Cameroon.
Pokaż więcej
Źródło:
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2022 Nov; Vol. 42 (11), pp. 2396-2402. Date of Electronic Publication: 2022 Aug 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HIV Infections*/complications
Hepatitis B*/diagnosis
Hepatitis C*/complications
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Adolescent ; Adult ; Aged ; Antigens, Surface ; Cameroon/epidemiology ; Cross-Sectional Studies ; Female ; Hepacivirus ; Hepatitis B Surface Antigens ; Hepatitis C Antibodies ; Humans ; Male ; Prevalence ; Risk Factors ; Young Adult
Czasopismo naukowe
Tytuł:
Multicenter performance evaluation of the Elecsys HCV Duo immunoassay.
Autorzy:
Majchrzak M; German Red Cross Blood Donor Service West GmbH, 184 Feithstrasse, 58097 Hagen, Germany.
Bronner K; Labor Augsburg MVZ GmbH, 5 August-Wessels-Strasse, 86154 Augsburg, Germany.
Laperche S; National Institute of Blood Transfusion, 6 Rue Alexandre Cabanel, 75015 Paris, France.
Riester E; Labor Augsburg MVZ GmbH, 5 August-Wessels-Strasse, 86154 Augsburg, Germany.
Bakker E; Sanquin Blood Supply Foundation, 125 Plesmanlaan, 1066 CX Amsterdam, the Netherlands.
Bollhagen R; Roche Diagnostics GmbH, 2 Nonnenwald, 82377 Penzberg, Germany.
Klinkicht M; Roche Diagnostics GmbH, 2 Nonnenwald, 82377 Penzberg, Germany.
Vermeulen M; South African National Blood Service, 1 Constantia Boulevard, Constantia Kloof, 1715 Roodepoort, South Africa.
Schmidt M; German Red Cross Blood Donor Service, 1 Sandhofstrasse, 60528 Frankfurt am Main, Germany. Electronic address: .
Pokaż więcej
Źródło:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology [J Clin Virol] 2022 Nov; Vol. 156, pp. 105293. Date of Electronic Publication: 2022 Sep 05.
Typ publikacji:
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C*
Nucleic Acids*
Hepacivirus ; Hepatitis C Antibodies ; Humans ; Immunoassay ; Sensitivity and Specificity ; Uronic Acids
Czasopismo naukowe
Tytuł:
Hepatitis C active viremia over time in an ED-based testing programme: Impact, disparities and surveillance tool.
Autorzy:
Reynolds L; Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Franco R; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Prados M; Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Rodgers JB; Division of Acute Care Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Hand DT; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Walter LA; Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Nov; Vol. 29 (11), pp. 1026-1034. Date of Electronic Publication: 2022 Sep 11.
Typ publikacji:
Journal Article
MeSH Terms:
Hepacivirus*
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Emergency Service, Hospital ; Hepatitis C Antibodies ; Humans ; RNA ; Retrospective Studies ; Viremia/diagnosis ; Viremia/epidemiology
Czasopismo naukowe
Tytuł:
Finding Cases of Hepatitis C for Treatment Using Automated Screening in the Emergency Department is Effective, but What Is the Cost?
Autorzy:
Prince DS; Liverpool Hospital, Sydney, NSW, Australia.; The Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.; The University of NSW, Sydney, NSW, Australia.
Girolamo JD; Liverpool Hospital, Sydney, NSW, Australia.; The Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.
Pipicella JL; Liverpool Hospital, Sydney, NSW, Australia.; The Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.
Bagatella M; Liverpool Hospital, Sydney, NSW, Australia.
Kayes T; Liverpool Hospital, Sydney, NSW, Australia.; The Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.
Alvaro F; Liverpool Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Liverpool, NSW, Australia.
Maley M; Liverpool Hospital, Sydney, NSW, Australia.; The University of NSW, Sydney, NSW, Australia.; NSW Health Pathology, Liverpool, NSW, Australia.
Foo H; Liverpool Hospital, Sydney, NSW, Australia.; NSW Health Pathology, Liverpool, NSW, Australia.; School of Medicine, Western Sydney University, Sydney, NSW, Australia.
Middleton PM; Liverpool Hospital, Sydney, NSW, Australia.; The Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.; The University of NSW, Sydney, NSW, Australia.; South Western Emergency Research Institute, UNSW, Sydney, NSW, Australia.; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia.
Levy MT; Liverpool Hospital, Sydney, NSW, Australia.; The Ingham Institute for Applied Medical Research, Sydney, NSW, Australia.; The University of NSW, Sydney, NSW, Australia.
Pokaż więcej
Źródło:
Canadian journal of gastroenterology & hepatology [Can J Gastroenterol Hepatol] 2022 Oct 14; Vol. 2022, pp. 3449938. Date of Electronic Publication: 2022 Oct 14 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C, Chronic*/drug therapy
Hepatitis C*/diagnosis
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Humans ; Hepacivirus/genetics ; Antiviral Agents/therapeutic use ; Australia ; Hepatitis C Antibodies ; Mass Screening/methods ; Emergency Service, Hospital ; RNA
Czasopismo naukowe
Tytuł:
Universal versus targeted screening for HCV infection in pregnancy in a diverse, multi-ethnic population: Universal screening is more comprehensive.
Autorzy:
Carey I; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Christiana M; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Marie-Ange M; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Teresa B; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Maria GV; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Dusheiko G; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Agarwal K; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Dec; Vol. 29 (12), pp. 1079-1088. Date of Electronic Publication: 2022 Sep 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Pregnancy Complications, Infectious*/diagnosis
Pregnancy Complications, Infectious*/epidemiology
Female ; Humans ; Pregnancy ; Child ; Male ; Infectious Disease Transmission, Vertical/prevention & control ; Seroepidemiologic Studies ; Mass Screening/methods ; Hepacivirus/genetics ; Hepatitis C Antibodies ; RNA ; Risk Factors
Czasopismo naukowe
Tytuł:
Risk factors for hepatitis C virus infection at a large urban emergency department.
Autorzy:
Ford JS; Department of Emergency Medicine, University of California, San Francisco, California, USA.
Hollywood E; A.T. Still University School of Osteopathic Medicine in Arizona, Mesa, Arizona, USA.
Steuble B; Touro University of California, College of Osteopathic Medicine, Vallejo, California, USA.
Meng Z; Department of Statistics, Graduate Group of Biostatistics, University of California Davis Health, Sacramento, California, USA.
Voong S; Department of Emergency Medicine, University of California, Davis, California, USA.
Chechi T; Department of Emergency Medicine, University of California, Davis, California, USA.
Tran N; Department of Pathology and Laboratory Medicine, University of California Davis Health, Sacramento, California, USA.
May L; Department of Emergency Medicine, University of California, Davis, California, USA.
Pokaż więcej
Źródło:
Journal of viral hepatitis [J Viral Hepat] 2022 Oct; Vol. 29 (10), pp. 930-937. Date of Electronic Publication: 2022 Jul 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepacivirus*/genetics
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Adult ; Aged ; Emergency Service, Hospital ; Female ; Hepatitis C Antibodies ; Humans ; Male ; Mass Screening/methods ; Medicare ; Middle Aged ; RNA ; Retrospective Studies ; Risk Factors ; Seroepidemiologic Studies ; United States
Czasopismo naukowe
Tytuł:
Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses.
Autorzy:
Mahmud S; Infectious Disease Epidemiology Group, Weill Cornell Medicine-, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
Chemaitelly H; Infectious Disease Epidemiology Group, Weill Cornell Medicine-, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar.; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar.
Alaama AS; Department of Communicable Diseases, HIV/Hepatitis/STIs Unit, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Hermez JG; Department of Communicable Diseases, HIV/Hepatitis/STIs Unit, World Health Organization Regional Office for the Eastern Mediterranean, Cairo, Egypt.
Abu-Raddad LJ; Infectious Disease Epidemiology Group, Weill Cornell Medicine-, Cornell University, Qatar Foundation - Education City, P.O. Box 24144, Doha, Qatar. .; World Health Organization Collaborating Centre for Disease Epidemiology Analytics On HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Qatar Foundation - Education City, Doha, Qatar. .; Department of Population Health Sciences, Weill Cornell Medicine, Cornell University, New York, NY, USA. .; Department of Public Health, College of Health Sciences, QU Health, Qatar University, Doha, Qatar. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 30; Vol. 12 (1), pp. 20637. Date of Electronic Publication: 2022 Nov 30.
Typ publikacji:
Journal Article
MeSH Terms:
Hepacivirus*
Hepatitis C*/epidemiology
Humans ; Prevalence ; Africa, Northern/epidemiology ; Middle East/epidemiology ; Hepatitis C Antibodies ; Regression Analysis
Czasopismo naukowe
Tytuł:
Induction of cross-neutralizing antibodies by a permuted hepatitis C virus glycoprotein nanoparticle vaccine candidate.
Autorzy:
Sliepen K; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands. .; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands. .
Radić L; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Capella-Pujol J; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Watanabe Y; School of Biological Sciences, University of Southampton, Southampton, UK.
Zon I; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Chumbe A; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Lee WH; Department of Structural Biology and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
de Gast M; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Koopsen J; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Koekkoek S; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Del Moral-Sánchez I; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Brouwer PJM; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Ravichandran R; Department of Biochemistry, University of Washington, Seattle, USA.; Institute for Protein Design, University of Washington, Seattle, USA.
Ozorowski G; Department of Structural Biology and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
King NP; Department of Biochemistry, University of Washington, Seattle, USA.; Institute for Protein Design, University of Washington, Seattle, USA.
Ward AB; Department of Structural Biology and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
van Gils MJ; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Crispin M; School of Biological Sciences, University of Southampton, Southampton, UK.
Schinkel J; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands.
Sanders RW; Amsterdam UMC, location University of Amsterdam, Department of Medical Microbiology and Infection Prevention, Laboratory of Experimental Virology, Amsterdam, The Netherlands. .; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, The Netherlands. .; Department of Microbiology and Immunology, Weill Medical College of Cornell University, New York, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2022 Nov 25; Vol. 13 (1), pp. 7271. Date of Electronic Publication: 2022 Nov 25.
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C*
Nanoparticles*
Vaccines*
Humans ; Hepacivirus/genetics ; Antibodies, Neutralizing ; Broadly Neutralizing Antibodies ; Viral Envelope Proteins ; Hepatitis C Antibodies ; Glycoproteins
Czasopismo naukowe
Tytuł:
Differential immune transcriptomic profiles between vaccinated and resolved HCV reinfected subjects.
Autorzy:
Mazouz S; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Québec, Canada.
Salinas E; Emory University School of Medicine, Emory University, Atlanta, Georgia, United States of America.; Emory National Primate Research Center, Atlanta, Georgia, United States of America.
Bédard N; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Filali A; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Khedr O; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.
Swadling L; Division of Infection and Immunity, University College London, London, United Kingdom.
Abdel-Hakeem MS; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Québec, Canada.
Siddique A; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de microbiologie, infectiologie et immunologie, Université de Montréal, Montréal, Québec, Canada.
Barnes E; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Bruneau J; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de médecine familiale et de médecine d'urgence, Université de Montréal, Montréal, Québec, Canada.
Grakoui A; Emory University School of Medicine, Emory University, Atlanta, Georgia, United States of America.; Emory National Primate Research Center, Atlanta, Georgia, United States of America.
Shoukry NH; Centre de Recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Montréal, Québec, Canada.; Département de médecine, Université de Montréal, Montréal, Québec, Canada.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Nov 15; Vol. 18 (11), pp. e1010968. Date of Electronic Publication: 2022 Nov 15 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Hepatitis C*
Vaccines*
Viral Hepatitis Vaccines*/genetics
Humans ; Hepacivirus/genetics ; Reinfection ; Transcriptome ; Hepatitis C Antibodies ; Antibodies, Neutralizing ; Viral Envelope Proteins
Czasopismo naukowe
Tytuł:
Neutralization and receptor use of infectious culture-derived rat hepacivirus as a model for HCV.
Autorzy:
Wolfisberg R; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Thorselius CE; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Salinas E; Emory Vaccine Center, Division of Microbiology and Immunology, Yerkes Research Primate Center, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Elrod E; Emory Vaccine Center, Division of Microbiology and Immunology, Yerkes Research Primate Center, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Trivedi S; Center for Vaccines and Immunity, Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Nielsen L; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Fahnøe U; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Kapoor A; Center for Vaccines and Immunity, Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
Grakoui A; Emory Vaccine Center, Division of Microbiology and Immunology, Yerkes Research Primate Center, Emory University School of Medicine, Atlanta, Georgia, USA.; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Rice CM; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.
Bukh J; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Holmbeck K; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Scheel TKH; Copenhagen Hepatitis C Program, Department of Infectious Diseases, Hvidovre Hospital, Copenhagen, Denmark.; Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.; Laboratory of Virology and Infectious Disease, The Rockefeller University, New York, New York, USA.
Pokaż więcej
Źródło:
Hepatology (Baltimore, Md.) [Hepatology] 2022 Nov; Vol. 76 (5), pp. 1506-1519. Date of Electronic Publication: 2022 May 12.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepacivirus*/genetics
Hepatitis C*
Rats ; Mice ; Animals ; Virus Replication/genetics ; Hepatitis C Antibodies ; Mice, SCID ; Viral Proteins
Czasopismo naukowe
Tytuł:
A pan-genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice.
Autorzy:
Donnison T; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
McGregor J; Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
Chinnakannan S; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Hutchings C; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Center RJ; Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.
Poumbourios P; Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology, Monash University, Clayton, Victoria, Australia.
Klenerman P; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Drummer HE; Burnet Institute, Melbourne, Victoria, Australia.; Department of Microbiology and Immunology at The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Victoria, Australia.; Department of Microbiology, Monash University, Clayton, Victoria, Australia.
Barnes E; Nuffield Department of Medicine, Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.; Nuffield Department of Medicine, Jenner Institute, University of Oxford, Oxford, UK.
Pokaż więcej
Źródło:
Hepatology (Baltimore, Md.) [Hepatology] 2022 Oct; Vol. 76 (4), pp. 1190-1202. Date of Electronic Publication: 2022 May 19.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C*/prevention & control
Vaccines*
Animals ; Antibodies, Neutralizing ; Antibodies, Viral ; CD8-Positive T-Lymphocytes ; Epitopes ; Genotype ; Hepacivirus/genetics ; Hepatitis C Antibodies ; Humans ; Mice ; Vaccinia virus/genetics
Czasopismo naukowe
Tytuł:
Misunderstanding of hepatitis C virus (HCV) infection status by non-specialized medical doctors in patients who achieved sustained virologic response to anti-HCV therapy.
Autorzy:
Toyoda H; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan. Electronic address: .
Yasuda S; Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan.
Moriya A; Department of Gastroenterology, Mitoyo General Hospital, Kannonji, Japan.
Itobayashi E; Department of Gastroenterology, Asahi General Hospital, Asahi, Japan.
Uojima H; Department of Gastroenterology, Internal Medicine, Kitasato University School of Medicine, Sagamihara, Japan.
Watanabe T; Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Atsukawa M; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Arai T; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Nippon Medical School, Tokyo, Japan.
Ishikawa T; Department of Hepatology, Saiseikai Niigata Hospital, Niigata, Japan.
Mikami S; Department of Internal Medicine, Division of Gastroenterology, Kikkoman General Hospital, Noda, Japan.
Hiraoka A; Gastroenterology Center, Ehime Prefectural Central Hospital, Matsuyama, Japan.
Tsuji K; Center of Gastroenterology, Teine Keijinkai Hospital, Sapporo, Japan.
Oikawa T; Department of Gastroenterology and Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo, Japan.
Tsubota A; Department of Gastroenterology and Core Research Facilities for Basic Science, The Jikei University School of Medicine, Tokyo, Japan.
Nozaki A; Gastroenterology Center, Yokohama City University Medical Center, Yokohama, Japan.
Chuma M; Gastroenterology Center, Yokohama City University Medical Center, Yokohama, Japan.
Abe H; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Shinmatusdo Central General Hospital, Matsudo, Japan.
Shima T; Department of Gastroenterology and Hepatology, Saiseikai Suita Hospital, Suita, Japan.
Kumada T; Department of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
Tanaka J; Department of Epidemiology, Infectious Disease Control, and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
Pokaż więcej
Źródło:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2022 Sep; Vol. 28 (9), pp. 1231-1234. Date of Electronic Publication: 2022 May 06.
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Hepatitis C*/drug therapy
Hepatitis C*/epidemiology
Hepatitis C, Chronic*/drug therapy
Antiviral Agents/therapeutic use ; Hepacivirus/genetics ; Hepatitis C Antibodies/therapeutic use ; Humans ; Sustained Virologic Response
Czasopismo naukowe
Tytuł:
Treating people where they are: Nurse-led micro-elimination of hepatitis C in supported housing sites for networks of people who inject drugs in Victoria, Canada.
Autorzy:
Selfridge M; Cool Aid Community Health Centre, Victoria, Canada.; University of Victoria, Victoria, Canada.
Barnett T; Cool Aid Community Health Centre, Victoria, Canada.
Lundgren K; Cool Aid Community Health Centre, Victoria, Canada.
Guarasci K; Cool Aid Community Health Centre, Victoria, Canada.
Milne R; Cool Aid Community Health Centre, Victoria, Canada.
Drost A; Cool Aid Community Health Centre, Victoria, Canada.
Fraser C; Cool Aid Community Health Centre, Victoria, Canada.; University of British Columbia, Victoria, Canada.
Pokaż więcej
Źródło:
Public health nursing (Boston, Mass.) [Public Health Nurs] 2022 Sep; Vol. 39 (5), pp. 1009-1016. Date of Electronic Publication: 2022 May 10.
Typ publikacji:
Journal Article
MeSH Terms:
Drug Users*
Hepatitis C*/drug therapy
Hepatitis C*/prevention & control
Hepatitis C, Chronic*/drug therapy
Substance Abuse, Intravenous*/complications
Antiviral Agents/therapeutic use ; Hepacivirus ; Hepatitis C Antibodies/therapeutic use ; Housing ; Humans ; Nurse's Role ; RNA/therapeutic use
Czasopismo naukowe
Tytuł:
Laboratory-based testing for hepatitis C infection using dried blood spot samples: A systematic review and meta-analysis of diagnostic accuracy.
Autorzy:
Carty PG; Faculty of Medicine & Health Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.; Health Information and Quality Authority, Dublin, Ireland.
McCarthy M; Health Information and Quality Authority, Dublin, Ireland.
O'Neill SM; Health Information and Quality Authority, Dublin, Ireland.
De Gascun CF; National Virus Reference Laboratory, University College Dublin, Dublin, Ireland.
Harrington P; Health Information and Quality Authority, Dublin, Ireland.
O'Neill M; Health Information and Quality Authority, Dublin, Ireland.
Smith SM; Department of General Practice, Health Research Board Centre for Primary Care Research, Royal College of Surgeons in Ireland, Dublin, Ireland.
Teljeur C; Health Information and Quality Authority, Dublin, Ireland.
Ryan M; Health Information and Quality Authority, Dublin, Ireland.; Department of Pharmacology & Therapeutics, Trinity College Dublin, Trinity Health Sciences, St James's Hospital, Dublin, Ireland.
Pokaż więcej
Źródło:
Reviews in medical virology [Rev Med Virol] 2022 Jul; Vol. 32 (4), pp. e2320. Date of Electronic Publication: 2021 Dec 26.
Typ publikacji:
Journal Article; Meta-Analysis; Review; Systematic Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C*/diagnosis
Hepatitis C, Chronic*
Dried Blood Spot Testing ; Hepacivirus/genetics ; Hepatitis C Antigens/analysis ; Humans ; RNA ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł:
Patient-derived monoclonal antibody neutralizes HCV infection in vitro and vivo without generating escape mutants.
Autorzy:
Yokokawa H; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Shinohara M; Medical & Biological Laboratories Co., Ltd., Tokyo, Japan.
Teraoka Y; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
Imamura M; Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Science, Hiroshima University, Hiroshima, Japan.; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
Nakamura N; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.
Watanabe N; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Date T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Aizaki H; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Iwamura T; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.
Narumi H; Pharmaceutical Research Laboratory, Toray Industries, Inc., Kanagawa, Japan.
Chayama K; Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.; Collaborative Research Laboratory of Medical Innovation, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.; RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Wakita T; Department of Virology II, National Institute of Infectious Diseases, Tokyo, Japan.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Sep 22; Vol. 17 (9), pp. e0274283. Date of Electronic Publication: 2022 Sep 22 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis C*
Hepatitis C, Chronic*
Animals ; Antibodies, Monoclonal ; Antibodies, Neutralizing ; Antiviral Agents/metabolism ; Epitopes ; Hepacivirus ; Hepatitis C Antibodies ; Humans ; Mice ; Peptide Library ; Viral Envelope Proteins
Czasopismo naukowe
Tytuł:
Diagnostic performances of Exacto® Triplex rapid test for diagnosis of HIV/HCV/HBsAg: a multicenter, cross-sectional, field study in the Central African Republic.
Autorzy:
Mossoro-Kpinde CD; Laboratoire National de Biologie Clinique et de Santé Publique, Bangui, République Centrafricaine.; Faculté des Sciences de la Santé, Université de Bangui, Bangui, République Centrafricaine.
Kalla GCM; Faculty of Medicine and Biomedical Science, University of Yaounde I, Yaounde, Cameroon.
Baguida-Bokia C; Laboratoire National de Biologie Clinique et de Santé Publique, Bangui, République Centrafricaine.
Sombot-Ndicki S; Laboratoire National de Biologie Clinique et de Santé Publique, Bangui, République Centrafricaine.
Bobossi C; Laboratoire National de Biologie Clinique et de Santé Publique, Bangui, République Centrafricaine.
Tonen-Wolyec S; Faculté de Médecine et de Pharmacie, Université de Kisangani, Kisangani, République Démocratique du Congo.
Mbopi-Kéou FX; Faculty of Medicine and Biomedical Science, University of Yaounde I, Yaounde, Cameroon.
Bélec L; Laboratoire de Virologie, Hôpital Européen Georges Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP) et Université Paris Cité, Paris, France.
Pokaż więcej
Źródło:
The Pan African medical journal [Pan Afr Med J] 2022 Sep 14; Vol. 43, pp. 21. Date of Electronic Publication: 2022 Sep 14 (Print Publication: 2022).
Typ publikacji:
Multicenter Study; Journal Article
MeSH Terms:
HIV Seropositivity*
HIV-1*
Hepatitis C*/diagnosis
Hepatitis C*/epidemiology
Adult ; Humans ; Hepatitis B Surface Antigens ; Hepacivirus ; Cross-Sectional Studies ; Central African Republic ; Hepatitis C Antibodies ; Antigens, Viral
Czasopismo naukowe
Tytuł:
Taking cues from convalescence to improve vaccines against hepatitis C virus.
Autorzy:
Sreekumar BK
Taha TY
Ott M
Pokaż więcej
Źródło:
The Journal of clinical investigation [J Clin Invest] 2022 Aug 01; Vol. 132 (15).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment
MeSH Terms:
Hepatitis C*
Hepatitis C, Chronic*
Vaccines*/metabolism
Viral Hepatitis Vaccines*
Antibodies, Neutralizing ; Antiviral Agents ; Broadly Neutralizing Antibodies ; Convalescence ; Cues ; Hepacivirus ; Hepatitis C Antibodies ; Humans ; Viral Envelope Proteins
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz